Effects of cannabidiol in comparison to hormonal therapy on estrogen decline‐induced memory impairments and endocannabinoid system in rats
Journal of Neuroendocrinology · 2026-07 · 38 (7)
DOI: 10.1111/jne.70234 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Neuroendocrinology, online erschienen am 20.07.2026. Verfasst von Fernanda Borsatto Caruso und 14 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Memory Dysfunctions, Department of Physiology, Institute for Basic Health Sciences, Federal University of Rio Grande do Sul, Porto Aleg…. Hauptthemen laut MEDLINE: Endocannabinoids, Cannabidiol, Memory Disorders, Estradiol. Die Arbeit nennt 79 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico, Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul.
Abstract (Originalsprache)
The aim of this study was to investigate the effects of cannabidiol (CBD) on memory deficits induced by ovariectomy and to directly compare its effects with those of hormone therapy, in order to better understand potential shared mechanisms related to menopause‐associated cognitive decline, with a particular focus on the endocannabinoid system. Three‐month‐old female Wistar rats were randomly assigned to four experimental groups: SHAM‐Veh (Vehicle), OVX‐Veh, OVX‐E2 (estradiol), and OVX‐CBD. Animals underwent either bilateral ovariectomy or sham surgery. Following a three‐week recovery period, rats received daily subcutaneous injections of CBD (10 mg/kg), estradiol (10 μg/kg), or vehicle for 21 consecutive days. Behavioral assessments included object recognition and fear‐motivated memory tests. Twenty‐four hours after the final treatment, animals were euthanized for neurochemical and molecular analyses. Levels of the endocannabinoids anandamide (AEA) and 2‐arachidonoylglycerol (2‐AG) were measured using high‐performance liquid chromatography. Gene expression of cannabinoid receptors CB1 and CB2, as well as enzymes involved in the synthesis and degradation of endocannabinoids (NAPE‐PLD, DAGL‐A, FAAH, and MGLL), was evaluated in the hippocampus by RT‐qPCR. The results demonstrated that CBD treatment produced memory improvements in the object recognition task comparable to those observed with estradiol. Ovariectomy‐induced impairments in fear‐motivated memory were completely reversed by both CBD and estradiol treatments. Additionally, CBD reduced the expression of FAAH and MGLL, resulting in increased hippocampal levels of AEA and 2‐AG, effects similar to those observed with hormone therapy. Estradiol also increased NAPE‐PLD expression, contributing to elevated AEA levels. Overall, the findings suggest that CBD exerts a protective effect on memory comparable to standard estrogen therapy, supporting its therapeutic potential for menopause‐related cognitive impairments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Memory Dysfunctions, Department of Physiology, Institute for Basic Health Sciences, Federal University of Rio Grande do Sul, Porto Alegre, Brazil.
- National Institute of Science and Technology for Translational Medicine (INCT-TM), Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Brasília, Brazil.
- Centro de Reprodução e Experimentação de Animais de Laboratório (CREAL), Institute for Basic Health Sciences, Federal University of Rio Grande do Sul, Porto Alegre, Brazil.
- Division of Molecular Metabolism, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
- Federal University of Health Sciences of Porto Alegre (UFCSPA), Porto Alegre, Brazil.
- Department of Neuroscience and Behavioral Sciences, Ribeirão Preto Medical School, University of São Paulo, São Paulo, Brazil.
ORCID-Profile: Fernanda Borsatto Caruso, Maria Paula Arakaki Severo, Anna Clara Machado Colucci, Beatriz Cristina Weidle Vuaden, Layza Kowalski, Patrícia Schonhofen, Felipe Schroeder Franke, Fernanda Bastos de Mello, Fernanda da Silva Rodrigues, Renata Padilha Guedes, Maria Noêmia Martins de Lima, Jaime E C Hallak, Antônio Waldo Zuardi, José Alexandre S Crippa, Nadja Schröder
Förderung
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul
Zitieren
APA
Caruso, F. B., Severo, M. P. A., Colucci, A. C. M., Vuaden, B. C. W., Kowalski, L., Schonhofen, P., Franke, F. S., de Mello, F. B., da Silva Rodrigues, F., Guedes, R. P., de Lima, M. N. M., Hallak, J. E. C., Zuardi, A. W., Crippa, J. A. S., & Schröder, N. (2026). Effects of cannabidiol in comparison to hormonal therapy on estrogen decline‐induced memory impairments and endocannabinoid system in rats. Journal of Neuroendocrinology, 38(7). https://doi.org/10.1111/jne.70234
Vancouver
Caruso FB, Severo MPA, Colucci ACM, Vuaden BCW, Kowalski L, Schonhofen P, et al. Effects of cannabidiol in comparison to hormonal therapy on estrogen decline‐induced memory impairments and endocannabinoid system in rats. Journal of Neuroendocrinology. 2026;38(7). doi:10.1111/jne.70234
BibTeX
@article{Caruso2026,
author = {Caruso, Fernanda Borsatto and Severo, Maria Paula Arakaki and Colucci, Anna Clara Machado and Vuaden, Beatriz Cristina Weidle and Kowalski, Layza and Schonhofen, Patrícia and Franke, Felipe Schroeder and de Mello, Fernanda Bastos and da Silva Rodrigues, Fernanda and Guedes, Renata Padilha and de Lima, Maria Noêmia Martins and Hallak, Jaime E C and Zuardi, Antônio Waldo and Crippa, José Alexandre S and Schröder, Nadja},
title = {Effects of cannabidiol in comparison to hormonal therapy on estrogen decline‐induced memory impairments and endocannabinoid system in rats},
journal = {Journal of Neuroendocrinology},
year = {2026},
volume = {38},
number = {7},
doi = {10.1111/jne.70234}
}
EUVIMED